Dr. Cheon Joo Yoon

D.D.S. | Dentist



  
  203 E Dalke Ave, Spokane
  Washington, 99208-8112

  509-444-8200    509-235-7742 Maps & Directions
Dr. Cheon Joo Yoon is a Spokane, Washington based Dentist who is specialized in Dentistry. He may accept the Medicare-approved amount. Patients may be billed for more than the Medicare deductible and coinsurance. His current practice location is 203 E Dalke Ave, Spokane. Patients can reach him at 509-444-8200.
Dr. Cheon Joo Yoon is the primary dental care provider for patients of all ages. He is responsible for the diagnosis, treatment, management and overall coordination of services related to patients' oral health needs.
Complete Profile:
Dr. Cheon Joo Yoon speciality, credentials, practice address, contact phone number and fax are as below. Patients can directly walk in or can call on the below given phone number for appointment.
Name: Dr. Cheon Joo Yoon
Specialization: Dentist
Gender:Male
Credentials: D.D.S.
Accepts Medicare Assignment:May Accept
Practice Address:203 E Dalke Ave, Spokane,
Washington, 99208-8112
Phone:509-444-8200
Fax:509-235-7742
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS). NPI details are as mentioned below.
PAC ID: 9830489988
Enrollment ID: I20160602001426
NPI Number: 1023370657
NPI Enumeration Date: 11 Jun, 2012
NPI Last Update On: 15 Oct, 2021

Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address: 611 N Iron Bridge Way,
Spokane, Washington
Zip: 99202-4932
Phone Number: 509-444-8888
Fax Number: 509-444-8888
Patients can reach Dr. Cheon Joo Yoon at 203 E Dalke Ave, Spokane, Washington or can call to book an appointment on 509-444-8200. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 November, 2024.

Comments/ Reviews: